Covid-19 hasn't been good for cancer research as all the focus was on the pandemic. Despite important learnings from Covid-19 on immunotherapy, cancer care and research into the disease have taken a hit in the past three years, he said.from Industry-Economic Times
Read The Rest:economictimes...
